Robinson Cole LLP
High Contrast Mode
Marquee

Health Care + Pharmaceutical

Robinson+Cole's construction lawyers are part of a multidisciplinary legal team that provides comprehensive legal support on health care and pharmaceutical projects. Facilities construction and renovation in this dynamic and fast-paced arena calls for experienced legal professionals who can identify and navigate the evolving regulatory, financing, design, procurement, and construction processes.

Our Services

Our construction lawyers work comfortably with facilities departments of health care and pharmaceutical clients throughout the planning, design, and construction of capital expansions and renovations. We understand the unique circumstances that such projects present. In addition, we have represented clients in negotiating contracts, resolving claims, and handling significant litigation for many hundreds of millions of dollars of health care and pharmaceutical construction. Because our experience is extensive, our work includes the following wide-ranging projects:

  • Hospitals
  • Bed towers
  • Medical centers
  • Ambulatory surgery centers
  • Diagnostic and treatment centers
  • Medical office buildings
  • Living communities
  • Emergency departments
  • Clinical simulation laboratories
  • Medical school facilities
  • Pharmaceutical facility de-commissionings
  • Biomedical research facilities
  • Chemical processing plants

Our Team

To provide comprehensive legal support for facilities construction by health care and pharmaceutical clients, our Construction Group collaborates with other firm practice groups in the following areas:

Health Law Group

  • Business strategies, including mergers and acquisitions
  • Governance
  • Regulatory compliance

Real Estate + Development Group

  • Site acquisition
  • Title
  • Zoning
  • Easements
  • Access

Environment + Utilities Group

  • Permitting
  • Power purchase
  • Alternative power
  • Environmental cleanup
  • Regulatory compliance
  • Brownfield redevelopment
  • Property value optimization

Finance + Public Finance Group

  • Project financing
  • Debt structure
  • Bond market financings
  • Borrowing
  • Incentives
  • Tax-exempt financing
  • Public/private partnerships

Experience


White Plains Hospital Inpatient Building in White Plains, New York

Represented White Plains Hospital in the drafting and negotiation of the design, consulting and construction contracts in connection with a new, state-of-the-art inpatient building on Davis Ave., where a parking garage currently exists. Our representation includes the demolition of the existing garage and associated sitework. The expansion of the existing 292-bed medical facility will allow the hospital to provide all private and single-patient rooms, expand the busy Emergency Room and add operating rooms.

Read More

Contract Negotiation for Construction of New Hospital Tower

Negotiation of a contract for the design and construction of a new hospital tower and expanded parking structure, totaling 260,000 square feet of new hospital space and 13,000 square feet of renovations. The $150 million project featured an expanded emergency department, a new critical care unit, a state-of-the-art neonatal intensive care unit, improved parking, and a heliport.

Read More

Contract Negotiation For Safety Testing Facility For Nonclinical Safety Studies

Negotiation of a contract for the construction of a new, 63,000-square-foot safety testing facility to be used for nonclinical safety studies in pharmaceutical development and research.



News


April 27, 2026

Ivy Miller Shares Update on Regulatory Reform of Pharmacy Benefit Managers in Massachusetts

Health Law group member Ivy K. Miller authored the article, “How PBM Reform Suddenly Got Rolling,” published in the March/April 2026 issue of the Massachusetts Bar Association’s Health Law Section Review. In the article, Ivy points out that there has been a significant shift in how pharmacy benefit managers (PBMs) are regulated at both the state and federal levels. “PBMs wield substantial leverage to bargain with drug companies and influence drug prices. One service that PBMs provide is to negotiate rebates that the drug companies pay to health plans. While lower co-pays may, in the short term, be a benefit to patients, high rebates typically result in drug companies raising the list price of the drug over time, which means higher consumer costs.” Ivy explains that bills at the federal level and in many states across the country, including Massachusetts, have laid out creative strategies for mitigating PBMs’ various revenue streams. In Massachusetts, the newly established application for licensure requires extensive documentation, including audited financial statements, disclosure of any “material ownership interest(s)” in any entity “whose business impacts the PBM,” and reporting of all claims, including the amounts of those claims, paid for Massachusetts residents in the prior year. “Requiring Massachusetts state licensure and reporting and federal attempts to rein in PBM compensation represent significant government actions toward controlling harms alleged as a result of PBMs’ market control, particularly for an industry that has been the subject of much scrutiny but little action to date.” Read the article.   

Massachusetts Bar Association, Health Law Section Review
May 8, 2014

Greg Faulkner Presents Legal Exposure Session at the Construction Institute

Construction Institute (CI)
April 27, 2026

Ivy Miller Shares Update on Regulatory Reform of Pharmacy Benefit Managers in Massachusetts

Health Law group member Ivy K. Miller authored the article, “How PBM Reform Suddenly Got Rolling,” published in the March/April 2026 issue of the Massachusetts Bar Association’s Health Law Section Review. In the article, Ivy points out that there has been a significant shift in how pharmacy benefit managers (PBMs) are regulated at both the state and federal levels. “PBMs wield substantial leverage to bargain with drug companies and influence drug prices. One service that PBMs provide is to negotiate rebates that the drug companies pay to health plans. While lower co-pays may, in the short term, be a benefit to patients, high rebates typically result in drug companies raising the list price of the drug over time, which means higher consumer costs.” Ivy explains that bills at the federal level and in many states across the country, including Massachusetts, have laid out creative strategies for mitigating PBMs’ various revenue streams. In Massachusetts, the newly established application for licensure requires extensive documentation, including audited financial statements, disclosure of any “material ownership interest(s)” in any entity “whose business impacts the PBM,” and reporting of all claims, including the amounts of those claims, paid for Massachusetts residents in the prior year. “Requiring Massachusetts state licensure and reporting and federal attempts to rein in PBM compensation represent significant government actions toward controlling harms alleged as a result of PBMs’ market control, particularly for an industry that has been the subject of much scrutiny but little action to date.” Read the article.   

Massachusetts Bar Association, Health Law Section Review
May 8, 2014

Greg Faulkner Presents Legal Exposure Session at the Construction Institute

Construction Institute (CI)

Events


Past

Connecticut Building Congress, Latest Developments in Construction Law

1998
Past

Connecticut Construction Law: What Do You Do When....?

1998
National Business Institute
Past

Connecticut Building Congress, Latest Developments in Construction Law

1998
Past

Connecticut Construction Law: What Do You Do When....?

1998
National Business Institute

Construction Law Zone


Massachusetts Construction Industry Continues To Wait While Prompt Payment Law Is Put To The Test

Earlier this month, the Massachusetts Supreme Judicial Court (SJC) heard argument in J.C. Cannistraro, LLC v. Columbia Construction Co. et al., a dispute concerning the state’s Prompt Payment Act (PPA). Although a decision has yet to be issued, it could potentially pose widespread implications for high-value private construction projects moving forward – and perhaps backwards....

Visit Blog

CA Civil Code § 8850: What Private Multi-state Owners and Developers Building in California in 2026 Need to Know

Owners and developers building in California must be aware of a new statute, CA Civil Code § 8850, which takes effect for contracts entered into, on, and after January 1, 2026. The statute will likely apply to most private construction projects; however, a carve-out exists for residential projects that are not mixed use and are...

Visit Blog

Fixed Price, Fluid Quantities: The Hidden Risks in Lump Sum Agreements with Variable Units

Lump sum construction agreements are the most basic of the different design-bid-build options: the contractor agrees to complete the entire scope of work for a fixed price, and assumes most of the quantity and cost risks. If the contractor’s actual costs exceed its estimates, the contractor absorbs the loss. Adding a clause into the construction...

Visit Blog

Navigating the DOT’s Interim Final Rule on DBE Certification Standards – and Preparing for the (Bumpy) Road Ahead

Last week, as a result of the federal government shutdown, news outlets reported on a pause in processing project reimbursements for the massive bi-state Hudson Tunnel Gateway Program and New York City’s Second Avenue Subway line. Beyond the political finger-pointing and investigation into the pause’s impact (the billions of dollars already appropriated remain untouched) is...

Visit Blog

The Importance of Indemnification Clauses in Managing Post-Completion Project Risk

Claims against design professionals often pose unique challenges when such claims are dually rooted in both tort and contract theories, and therefore subject to competing time limitations. To reconcile these differences, Massachusetts courts have historically looked to the “gist” of a given claim, rather than the label, to assess the appropriate limitations. A determination that...

Visit Blog

The Long-Standing Waiver for Manufactured Products from FHWA’s Buy America Requirements is Phasing Out

Amidst the flurry of tariff threats swirling around the world, the Federal Highway Administration (FHWA) is terminating the waiver known as the Manufactured Products General Waiver from the Buy America requirements found in 23 U.S.C.A § 313. The Buy America regulation requires all federal-aid projects to use only steel, iron, and manufactured products that are...

Visit Blog

Under New York Law a Recourse Provision Bars Most Claims Except for Fraud

In Iberdrola Energy Projects v. Oaktree Capital Management L.P., 231 A.D.3d 33, 216 N.Y.S.3d 124, the Appellate Division for the First Department ruled that a nonrecourse provision in a contract barred a plaintiff’s causes of action for tortious interference with contract, unjust enrichment, and statutory violations of a trade practices statute, but not for fraud....

Visit Blog

More Executive Orders Addressing the Size and Authority of the Federal Government

This post was co-authored by Government Enforcement + White Collar Defense Team lawyer David Carney, Capital Markets + Securities Group lawyer Tiange (Tim) Chen, and Antitrust + Regulation team co-chair Jennifer Driscoll. Executive Order Directing Deregulation and Termination of Certain Regulatory Enforcement Actions On February 19, 2025, in an executive order titled Ensuring Lawful Governance and...

Visit Blog

Requirements For Professional Engineers Practicing in Connecticut

Many out-of-state professional engineering companies practice engineering in Connecticut and may not be aware of all the requirements to do so. Connecticut has certain requirements for corporations and limited liability companies (LLCs) engaging in the practice of engineering. The applicable law, General Statutes §§ 20-306a and 20-306b, requires that (1) the personnel who act as...

Visit Blog

Executive Order Update on Construction Materials

This post was authored by International team lawyer Kathleen Porter. Executive Order Adjusting Imports of Aluminum into The United States On February 11, 2025, in an executive order titled Adjusting Imports of Aluminum into the United States, President Trump increased, from 10% to 25%, the ad valorem tariff rate on imports of aluminum and aluminum-derivative articles...

Visit Blog